ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 263 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $937 | -76.2% | 57,664 | -72.9% | 0.00% | -80.0% |
Q1 2024 | $3,937 | -41.1% | 212,923 | -0.3% | 0.01% | -44.4% |
Q4 2023 | $6,689 | +37.5% | 213,639 | -8.5% | 0.01% | +28.6% |
Q3 2023 | $4,866 | +25.1% | 233,509 | +43.8% | 0.01% | +40.0% |
Q2 2023 | $3,889 | +227.4% | 162,368 | +157.2% | 0.01% | +150.0% |
Q1 2023 | $1,188 | -13.0% | 63,131 | -26.4% | 0.00% | 0.0% |
Q4 2022 | $1,365 | -99.9% | 85,735 | -0.1% | 0.00% | 0.0% |
Q3 2022 | $1,403,000 | +25.7% | 85,779 | +8.3% | 0.00% | +100.0% |
Q2 2022 | $1,116,000 | -46.6% | 79,233 | -8.2% | 0.00% | -50.0% |
Q1 2022 | $2,090,000 | +3.9% | 86,287 | +0.1% | 0.00% | 0.0% |
Q4 2021 | $2,012,000 | +40.1% | 86,210 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $1,436,000 | -42.1% | 86,432 | -15.0% | 0.00% | -33.3% |
Q2 2021 | $2,480,000 | -20.8% | 101,700 | -16.2% | 0.00% | 0.0% |
Q1 2021 | $3,130,000 | -59.1% | 121,300 | -15.4% | 0.00% | -66.7% |
Q4 2020 | $7,661,000 | +16.1% | 143,300 | -10.4% | 0.01% | +12.5% |
Q3 2020 | $6,596,000 | -24.7% | 159,900 | -11.5% | 0.01% | -27.3% |
Q2 2020 | $8,755,000 | +86.9% | 180,630 | +62.9% | 0.01% | +57.1% |
Q1 2020 | $4,684,000 | -10.8% | 110,865 | -9.7% | 0.01% | +16.7% |
Q4 2019 | $5,253,000 | +14.7% | 122,780 | -3.5% | 0.01% | 0.0% |
Q3 2019 | $4,580,000 | +58.8% | 127,250 | +17.9% | 0.01% | +50.0% |
Q2 2019 | $2,884,000 | -8.6% | 107,900 | -8.1% | 0.00% | 0.0% |
Q1 2019 | $3,154,000 | +96.3% | 117,470 | +18.2% | 0.00% | +100.0% |
Q4 2018 | $1,607,000 | -29.3% | 99,400 | -9.2% | 0.00% | -33.3% |
Q3 2018 | $2,273,000 | +35.9% | 109,500 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $1,672,000 | -64.8% | 109,500 | -48.2% | 0.00% | -66.7% |
Q1 2018 | $4,748,000 | -24.1% | 211,300 | +1.7% | 0.01% | -25.0% |
Q4 2017 | $6,257,000 | -22.7% | 207,800 | -3.3% | 0.01% | -20.0% |
Q3 2017 | $8,092,000 | +39.3% | 214,800 | +3.1% | 0.01% | +25.0% |
Q2 2017 | $5,809,000 | -18.9% | 208,300 | -0.0% | 0.01% | -20.0% |
Q1 2017 | $7,161,000 | +24.3% | 208,301 | +4.3% | 0.01% | +25.0% |
Q4 2016 | $5,762,000 | -8.3% | 199,800 | +1.2% | 0.01% | -11.1% |
Q3 2016 | $6,281,000 | +0.2% | 197,469 | +2.2% | 0.01% | 0.0% |
Q2 2016 | $6,271,000 | +111.8% | 193,179 | +82.4% | 0.01% | +80.0% |
Q1 2016 | $2,961,000 | -12.6% | 105,885 | +11.4% | 0.01% | 0.0% |
Q4 2015 | $3,387,000 | +22.5% | 95,020 | +13.6% | 0.01% | +25.0% |
Q3 2015 | $2,765,000 | -45.1% | 83,620 | -30.4% | 0.00% | -42.9% |
Q2 2015 | $5,032,000 | +453.6% | 120,162 | +330.8% | 0.01% | +600.0% |
Q1 2015 | $909,000 | -15.9% | 27,893 | -18.1% | 0.00% | -50.0% |
Q4 2014 | $1,081,000 | – | 34,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |